kidney injury
CareDx Stock Rises as Study Shows Cell-Free DNA's Utility for Kidney Allograft Rejection Detection
The Nature Medicine study illustrated the value of CareDx's AlloSure test for monitoring kidney transplant rejection beyond stand-of-care measures.
Acute Kidney Injury Markers Found With Single-Cell Transcriptomics, Proteomics
After identifying expression changes linked to maladaptive kidney injury repair, researchers used plasma proteomics to find potential markers for severe kidney injury and progression.
CareDx to Study AlloSure Kidney for Routine Organ Transplant Surveillance in Pediatric Patients
The company is teaming up with the North American Pediatric Renal Trials and Collaborative Studies organization to study the long-term impact of AlloSure.
Eurofins Viracor, Cleveland Clinic Sign License Deal for Kidney Transplant Rejection Biomarker Test
The test, which was developed by researchers at the Cleveland Clinic and the University of Alabama, looks for RNA molecules in urine that indicate rejection.
CareDx, Weill Cornell Codeveloping Kidney Transplant Rejection Test
The partners are planning to develop and commercialize UroMap, a urine-based gene-expression test for acute cellular rejection in kidney transplant recipients.